Canopy Growth | Global Edible Extracts & Spectrum Therapeutics

Role: Global Head of Edible Extracts, Canopy Growth Corporation | July 2020 – April 2022.

I led a global edible extracts portfolio with more than $100 million in P&L responsibility across Europe, North America and Asia-Pacific, spanning medical, recreational and over-the-counter markets.

Global Portfolio & P&L Leadership

As Global Head of Edible Extracts, I was responsible for new product development, marketing, portfolio management and go-to-market strategy for oils, softgels and edible extracts across THC and CBD categories. The portfolio operated across multiple geographies, consumer needs and regulatory frameworks.

Spectrum Therapeutics: Medical Brand Leadership

I served as brand owner for Spectrum Therapeutics, described in my executive résumé as the world’s second-largest medical cannabis brand during my tenure. This historical ranking should be independently verified before publication.

Innovation for the Medical Community

I led the launch of a THC-free CBD isolate under the Spectrum Therapeutics brand in the Canadian medical cannabis market, expanding the brand’s cannabinoid product portfolio for medical patients and healthcare practitioners. The claim that this was the first such product in the market remains subject to independent verification before publication.

Resilience & Financial Performance During COVID-19

Despite COVID-19 disruptions, my business achieved its budget while maintaining average margins above 60%, making it one of the few categories within Canopy Growth to meet its financial targets during that period, according to my executive résumé.

Martha Stewart CBD: U.S. Launch

I successfully launched Martha Stewart CBD oils and softgels in the U.S. market, bringing a consumer-facing product line to market through coordinated product development, portfolio planning and commercialization.

What This Demonstrates

Global P&L accountability, multi-market portfolio leadership, regulated-category innovation, medical and consumer brand management, disciplined margin performance and U.S. product commercialization.

Explore my BioSteel & This Works portfolio leadership case study →

Discuss an executive or advisory opportunity →